Abstract:Introduction Although deficits in neurocognitive functioning and emotional recognition impact treatment outcomes in schizophrenia since the development of the first psychotic episode (FEP), there is still a lack of longer follow-up studies showing the course of these deficits over time. Objectives Our objective is to investigate the changes of cognitive functioning over years in a cohort of patients, since their FEP. Methods This study is developed as a follow-up of the project Biomarkers in schizophrenia- integration of complementary methods in longitudinal follow-up of FEP, that was conducted in several Croatian psychiatric clinics during the period from 2014 to 2019. A cohort of patients with FEP took part in the project with psychopathology, neurocognitive functioning and emotional recognition assessment at two time points- at baseline, during the subacute phase of a psychotic episode, and after 18 months of follow-up. In this study, patients with FEP who completed the baseline assessment of the project (n=159), will be contacted and included in the follow- up. Follow-up assessment will consist of sociodemographic data including information of their treatment so far, battery of neurocognitive tests (Rey Auditory Verbal Learning Test, Rey–Osterrieth complex figure Test, Wechsler paired memory, trail making test a & b, Digit symbol, Digit span, Semantic & Phonetic Fluency, Stroop 1, 2, 3 and Block design test), emotional recognition test (Penn Emotion Recognition Task) and several scales assessing psychopathology (Positive and Negative Syndrome Scale, Self-evaluation of Negative Symptoms, Scale for the Assessment of Negative Symptoms), functioning (Global Assessment of Functioning, WHO Disability Assessment Scale 2.0), quality of life and recovery. The study is funded by the University of Zagreb programmes (Project No. 10106-23-2394). Results We plan to analyze the differences between the three time points (baseline, 18 months, 5 years), taking in account possible correlations with psychopathology, functioning, quality of life and different treatment options. Conclusions Identifying specific deficits can help in providing more effective treatment plan including various interventions that can improve treatment outcomes in schizophrenia. Disclosure of Interest None Declared

Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from a 2-year follow-up study in Italy

Treatment of depression in first episode of schizophrenia: results from EUFEST.

Persistent Negative Symptoms in First Episode Patients with Schizophrenia: Results from the European First Episode Schizophrenia Trial

Anhedonia and suicidal ideation in young people with early psychosis: findings from a 2-year Italian follow-up study.

Depressive symptoms in first-episode schizophrenia:A 9-year follow-up study

A Naturalistic Cohort Study of First-Episode Schizophrenia Spectrum Disorder: A Description of the Early Phase of Illness in the PSYSCAN Cohort.

Additive effects of a family history of schizophrenia spectrum disorders and an environmental risk score for the outcome of patients with non-affective first-episode psychosis

The Role of Depression in the Prediction of a “late” Remission in First-Episode Psychosis: an Analysis of the OPTiMiSE Study

First Episode Psychoses in people over-35 years old: uncovering potential actionable targets for Early Intervention Services.

Trajectories of Suicidal Risk among Individuals with First-Episode Psychosis: Relationship to Recovery and Symptoms

Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders

The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years

Citalopram in First Episode Schizophrenia: the DECIFER Trial.

Insight and Suicidality in First Episode Psychosis: The Mediating Role of Depression

Neurocognitive functioning and emotional recognition in first-episode psychosis: protocol for a follow- up study

Dimensions and predictors of clinical and personal recovery in first‐episode psychoses: Results from a cross‐sectional study

Predictors of Discontinuation of Antipsychotic Medication and Subsequent Outcomes in the European First Episode Schizophrenia Trial (EUFEST).

Unmet Needs in Patients with First-Episode Schizophrenia: a Longitudinal Perspective

Suicidal thinking and behavior in young people at Clinical High Risk for Psychosis: Psychopathological considerations and treatment response across a 2‐year follow‐up study

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?

Clinical, psychological and brain imaging investigation of first episode psychosis patients treated at Semmelweis University, Department of Psychiatry and Psychotherapy, Budapest, Hungary